USPTO serial 87807055
USHSTAT
Reviewed by CopyMark Law Group
Reg. 5700940Status 710
- Filing date
- Status date
- Registration date
- Mar 19, 2019
- Examiner
- SHINER, MARK W
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with USHSTAT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Oxford OX4 6LT, GB
Oxford OX4 6LT, GB
Oxford OX4 6LT, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Roberta S. Bren
ROBERTA S. BREN MUNCY, GEISSLER, OLDS & LOWE, P.C.4000 LEGATO ROAD, SUITE 310FAIRFAX, VA 22033UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Enzymes for scientific and research purposes; chemicals for use in industry and science, namely, chemicals for in-vitro use and analysis in laboratories; micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, nucleic acid sequences and chemical reagents for other than medical and veterinary purposes, namely, cloning vehicles and vectors and recombinant deoxyribonucleic acid variations thereof, all for in-vitro and in-vivo use in laboratory or medical research; chemical reagents for use in medical science | SECTION 8 - CANCELLED | — |
| 005 | Gene therapy products, namely, genetically engineered tissues for transplant purposes and gene delivery pharmaceuticals; vaccines, enzymes and enzyme preparations, anti-apoptopic and angiostatic/angiogenic molecules, all for medical purposes; nucleic acid sequences and chemical reagents for medical purposes, namely, retroviral vectors and retroviral vector manufacturing preparations; pharmaceutical and biochemical preparations for the treatment of diseases of the eye and Usher's disease; biochemical preparations for medical purposes, namely, gene based therapeutics for the treatment of a juvenile degenerative retinal disease; pre-filled vials containing gene therapy pharmaceutical preparations | SECTION 8 - CANCELLED | — |
| 010 | Medical instruments and apparatus for the administration of antibody-based therapy, gene therapy and prophylaxis preparations and substances; syringes and injectors for medical purposes | SECTION 8 - CANCELLED | — |
| 042 | Scientific and medical research and development; genetic engineering services, biotechnology services, namely, research and development of new products for others in the field of biotechnology; advisory services relating to research and development of gene therapy products | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Oxford BioMedica Plc
- Other trademarks owned by Oxford BioMedica Plc
- Other trademarks owned by Oxford BioMedica Plc
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named USHSTAT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 3, 2025 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Mar 19, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Mar 19, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 12, 2019 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Feb 12, 2019 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 9, 2019 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Jan 9, 2019 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| Sep 11, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 17, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 17, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 27, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 8, 2018 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jun 8, 2018 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jun 8, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 7, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 28, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 26, 2018 | NWAP | NEW APPLICATION ENTERED | — |